Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-05

Clinical Trial Update: Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating cessation of cotrimoxazole prophylaxis in adults with HIV infection stabilized on HAART in Entebbe, Uganda. The trial status is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cotrimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN